Enhancer I predominance in hepatitis B virus gene expression

Area of Science:

• Virology
• Molecular Biology
• Gene Regulation

Background:

• Human hepatitis B virus (HBV) transcription involves two enhancer elements, Enhancer I (EnhI) and Enhancer II (EnhII).
• The interplay and specific roles of EnhI and EnhII in regulating HBV transcription have not been fully elucidated.
• EnhI interacts with basic leucine zipper proteins, while EnhII primarily interacts with nuclear receptors (NRs).

Purpose of the Study:

• To investigate the functional relationship and interplay between EnhI and EnhII in regulating HBV transcription.
• To determine the contribution of each enhancer to early and late HBV transcript production.
• To understand the role of EnhI in the temporal regulation of HBV gene expression.

Main Methods:

• Time course analysis of HBV transcripts in Chang cells.
• Manipulation of enhancer activity by replacing EnhI with a synthetic Gal4 response (UAS) DNA fragment.
• Overexpression of specific nuclear receptors (NRs) and Gal4 fusion proteins (Gal4-p53, Gal4-VP16).

Main Results:

• Chang cells showed impaired late HBV transcript expression, correctable by EnhII activator overexpression, indicating active EnhI but inactive EnhII.
• Replacing EnhI with UAS abolished early transcripts and impaired EnhII activation by NRs.
• Activation of UAS by Gal4-p53 restored both early transcripts and NR-mediated EnhII activation, demonstrating EnhI's requirement for EnhII function.
• Differential effects of Gal4-p53 and Gal4-VP16 on early and late transcripts suggest EnhI-binding proteins influence temporal switching.

Conclusions:

• A functional EnhI is essential for the activation of EnhII and global HBV gene expression.
• The composition of proteins binding to EnhI plays a critical role in the temporal regulation of HBV gene expression, specifically the switch from early to late transcripts.
• These findings provide significant insights into the regulatory mechanisms governing HBV transcription.